Rocket Companies RKT Climbs 157 Resistance at 1424 in Focus 20260518 Shoals SHLS Q1 2026 Earnings EPS 007 Beats Estimates Pasithea Therapeutics KTTA Q4 2025 Disappoints EPS 079 Below 018 Views Senmiao Tech AIHS Stalls at 119 Consolidation Phase 20260519 Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday China Coking Coal Prices Surge Following Fatal Shanxi Mine Incident CBSE Exam Portal Glitches and Hack Claims Prompt Government Investigation Iran Israel and Arab Nations Are Bound by a New Balance of Terror Memorial Day Market Perspectives Key Takeaways on Walmart Nvidia and GameStop Spain Blocks Polymarket and Kalshi Access Amid Gambling License Probe FTI Consulting FCN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick ANNX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines on PreRevenue Status ARLP Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue Disclosure NX Q1 2026 Earnings Earnings Beat Estimates Despite Negative EPS Proficient Auto Logistics Inc PAL Q1 2026 Earnings Massive EPS Surprise Driven by Operational Efficiency NexGel Inc NXGL Q1 2026 Earnings EPS Miss on Higher Operating Costs Arqit Quantum ARQQ Shows Resilience Despite Recent Dip Key Levels to Watch Cemex CX Holds Steady Near Resistance as Volume Signals Caution Logitech LOGI Edges Lower as Technical Indicators Point to Consolidation Graham Corporation GHM Holds Near Support as Slight Decline Tests Key Levels Viemed Healthcare VMD Rises 281 Approaching Key Resistance Level HCM III Acquisition Corp Warrants HCMAW Edge Higher Support Holds as SPAC Warrant Gains 35 Eagle Point Credit Notes ECCW Steady Near Par as FixedIncome Market Consolidates Natural Health Trends Corp NHTC Slides as Price Approaches Key Support Level Kirby Corporation KEX Declines 157 as Stock Tests Key Support Zone US Physical Therapy USPH Gains 332 as Stock Tests Resistance Levels Oxford Lane Capital Preferred OXLCO Holds Near Support Amid Modest Decline British Startup BioOrbit Sends DrugCrystallization Technology to ISS for Potential Cancer Treatment Breakthrough Schneider National Q1 2026 Earnings EPS Beats Estimates Stock Moves Modestly Higher Alliance Resource Partners ARLP Holds Steady Amid Mixed Market Signals VYGR Q1 2026 Earnings Adjusted Loss Narrower Than Expected Despite No Revenue Equinox Gold EQX Q1 2026 Earnings Marginal EPS Miss Amid Gold Price Tailwinds Shares Dip 2 OneSpan Inc Q1 2026 Earnings EPS Beats Estimates by 1335 Amid Solid Execution Aytu BioPharma Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Coeur Mining CDE Q1 2026 Earnings EPS Miss Highlights Cost Pressures on Bottom Line Cytokinetics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Focus Intensifies Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress